Technical Analysis for INSM - Insmed, Inc.

Grade Last Price % Change Price Change
grade A 24.69 6.28% 1.46
INSM closed up 6.28 percent on Thursday, January 17, 2019, on 1.42 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical INSM trend table...

Date Alert Name Type % Chg
Jan 17 180 Bullish Setup Bullish Swing Setup 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 16 Wide Bands Range Expansion 6.28%
Jan 16 Overbought Stochastic Strength 6.28%
Jan 15 180 Bullish Setup Bullish Swing Setup 5.74%
Jan 15 Pocket Pivot Bullish Swing Setup 5.74%
Jan 15 Wide Bands Range Expansion 5.74%
Jan 15 Overbought Stochastic Strength 5.74%
Jan 14 Slingshot Bullish Bullish Swing Setup 11.82%

Older signals for INSM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing targeted inhalation therapies for patients battling serious lung diseases. Its lead candidate ARIKACE is engineered to deliver a proven and potent anti-infective directly to the site of serious lung infections to improve the treatment for two identified patient populations comprising cystic fibrosis (CF) patients with Pseudomonas aeuruginosa lung infections and patients with nontuberculous mycobacteria lung infections (NTM). The company's Phase III registrational study of ARIKACE in CF patients in Europe and Canada has completed enrollment; and Phase II clinical trial in NTM patients is under way with clinical results. Insmed Incorporated was founded in 1999 and is headquartered in Monmouth Junction, New Jersey.
Is INSM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 31.58
52 Week Low 11.31
Average Volume 1,049,591
200-Day Moving Average 21.3825
50-Day Moving Average 16.8943
20-Day Moving Average 17.3395
10-Day Moving Average 21.708
Average True Range 1.4964
ADX 40.33
+DI 38.9804
-DI 8.1361
Chandelier Exit (Long, 3 ATRs ) 20.3308
Chandelier Exit (Short, 3 ATRs ) 15.7992
Upper Bollinger Band 26.8381
Lower Bollinger Band 7.8409
Percent B (%b) 0.89
BandWidth 109.560253
MACD Line 2.284
MACD Signal Line 1.3562
MACD Histogram 0.9277
Fundamentals Value
Market Cap 1.54 Billion
Num Shares 62.4 Million
EPS -3.04
Price-to-Earnings (P/E) Ratio -8.12
Price-to-Sales 0.00
Price-to-Book 20.05
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.64
Resistance 3 (R3) 26.47 25.64 26.32
Resistance 2 (R2) 25.64 25.15 25.73 26.21
Resistance 1 (R1) 25.17 24.84 25.41 25.34 26.10
Pivot Point 24.34 24.34 24.46 24.43 24.34
Support 1 (S1) 23.87 23.85 24.11 24.04 23.28
Support 2 (S2) 23.04 23.54 23.13 23.17
Support 3 (S3) 22.57 23.04 23.07
Support 4 (S4) 22.74